What is Nano-X Imaging Ltd.'s earnings per share (EPS)?

Nano-X Imaging Ltd. (NNOX) reported diluted earnings per share of $-0.91 for fiscal year 2024. This represents a 15.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nano-X Imaging Ltd. Financials

NNOX

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2024 Currency USD FYE December

This page shows Nano-X Imaging Ltd. (NNOX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 43/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Nano-X Imaging Ltd. has an operating margin of -502.9%, meaning the company retains $-503 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -631.9% the prior year.

Growth

Nano-X Imaging Ltd.'s revenue grew 13.9% year-over-year to $11.3M, a solid pace of expansion. This earns a growth score of 57/100.

Leverage

100

Nano-X Imaging Ltd. carries a low D/E ratio of 0.11, meaning only $0.11 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 5.63, Nano-X Imaging Ltd. holds $5.63 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

While Nano-X Imaging Ltd. generated -$36.6M in operating cash flow, capex of $2.8M consumed most of it, leaving -$39.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Nano-X Imaging Ltd. generates a -28.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -31.1% the prior year.

Piotroski F-Score Weak

3/9

Nano-X Imaging Ltd. passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.68x

For every $1 of reported earnings, Nano-X Imaging Ltd. generates $0.68 in operating cash flow (-$36.6M OCF vs -$53.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.3M

YoY+13.9%

Nano-X Imaging Ltd. generated $11.3M in revenue in fiscal year 2024. This represents an increase of 13.9% from the prior year.

EBITDA

-$45.0M

YoY+11.4%

Nano-X Imaging Ltd.'s EBITDA was -$45.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.4% from the prior year.

Net Income

-$53.5M

YoY+11.9%

Nano-X Imaging Ltd. reported -$53.5M in net income in fiscal year 2024. This represents an increase of 11.9% from the prior year.

EPS (Diluted)

$-0.91

YoY+15.7%

Nano-X Imaging Ltd. earned $-0.91 per diluted share (EPS) in fiscal year 2024. This represents an increase of 15.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$39.4M

YoY+18.1%

Nano-X Imaging Ltd. generated -$39.4M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 18.1% from the prior year.

Cash & Debt

$39.3M

YoY-30.3%

5Y CAGR+37.2%

Nano-X Imaging Ltd. held $39.3M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

64M

YoY+10.4%

5Y CAGR+18.6%

Nano-X Imaging Ltd. had 64M shares outstanding in fiscal year 2024. This represents an increase of 10.4% from the prior year.

Margins & Returns

Gross Margin

-94.0%

YoY-27.5pp

Nano-X Imaging Ltd.'s gross margin was -94.0% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 27.5 percentage points from the prior year.

Operating Margin

-502.9%

YoY+129.0pp

Nano-X Imaging Ltd.'s operating margin was -502.9% in fiscal year 2024, reflecting core business profitability. This is up 129.0 percentage points from the prior year.

Net Margin

-474.3%

YoY+139.3pp

Nano-X Imaging Ltd.'s net profit margin was -474.3% in fiscal year 2024, showing the share of revenue converted to profit. This is up 139.3 percentage points from the prior year.

Return on Equity

-28.3%

YoY+2.8pp

Nano-X Imaging Ltd.'s ROE was -28.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 2.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$20.2M

YoY-22.5%

5Y CAGR+49.3%

Nano-X Imaging Ltd. invested $20.2M in research and development in fiscal year 2024. This represents a decrease of 22.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$2.8M

YoY-16.2%

5Y CAGR+85.8%

Nano-X Imaging Ltd. invested $2.8M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 16.2% from the prior year.

NNOX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$11.3M+13.9%	$9.9M+15.5%	$8.6M+3077.0%	$270K	N/A	N/A
Cost of Revenue	$21.9M+32.7%	$16.5M+6.7%	$15.5M+448.9%	$2.8M	N/A	N/A
Gross Profit	-$10.6M-60.9%	-$6.6M+4.2%	-$6.9M-355.0%	-$1.5M	N/A	N/A
R&D Expenses	$20.2M-22.5%	$26.0M-1.7%	$26.5M+54.8%	$17.1M+85.9%	$9.2M+239.0%	$2.7M
SG&A Expenses	$22.5M-7.5%	$24.3M-41.2%	$41.3M+18.9%	$34.7M+55.9%	$22.3M+21.7%	$18.3M
Operating Income	-$56.7M+9.3%	-$62.6M+46.8%	-$117.7M-91.2%	-$61.6M-40.1%	-$43.9M-94.6%	-$22.6M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$358K-5.6%	-$339K+90.8%	-$3.7M-7562.5%	-$48K	N/A	N/A
Net Income	-$53.5M+11.9%	-$60.8M+46.3%	-$113.2M-83.2%	-$61.8M-41.0%	-$43.8M-94.2%	-$22.6M
EPS (Diluted)	$-0.91+15.7%	$-1.08+50.2%	$-2.17-69.5%	$-1.28-4.1%	$-1.23	N/A

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

NNOX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$210.0M-4.0%	$218.6M-13.9%	$253.9M-30.1%	$363.2M+53.8%	$236.1M+1889.3%	$11.9M
Current Assets	$78.7M-11.2%	$88.6M+7.5%	$82.5M-13.1%	$94.9M-56.8%	$219.8M+2181.0%	$9.6M
Cash & Equivalents	$39.3M-30.3%	$56.4M+46.6%	$38.5M-42.3%	$66.6M-68.8%	$213.5M+2544.5%	$8.1M
Inventory	$1.5M-36.6%	$2.4M	N/A	$116K	N/A	N/A
Accounts Receivable	$112K+103.6%	$55K+61.8%	$34K	N/A	N/A	N/A
Goodwill	N/A	N/A	$7.4M-87.3%	$58.3M	N/A	N/A
Total Liabilities	$20.9M-9.7%	$23.1M-37.9%	$37.3M-47.5%	$71.0M+1214.5%	$5.4M-73.8%	$20.6M
Current Liabilities	$14.0M-10.0%	$15.5M-38.1%	$25.1M-52.5%	$52.8M+1077.5%	$4.5M-77.9%	$20.3M
Long-Term Debt	N/A	N/A	$3.5M	N/A	N/A	N/A
Total Equity	$189.1M-3.3%	$195.5M-9.8%	$216.7M-25.8%	$292.1M+26.6%	$230.7M+2728.7%	-$8.8M
Retained Earnings	-$373.7M-16.7%	-$320.2M-23.4%	-$259.5M-77.5%	-$146.2M-73.2%	-$84.4M-107.9%	-$40.6M

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19
Total Assets	$210.0M-4.0%	$218.6M-13.9%	$253.9M-30.1%	$363.2M+53.8%	$236.1M+1889.3%	$11.9M
Current Assets	$78.7M-11.2%	$88.6M+7.5%	$82.5M-13.1%	$94.9M-56.8%	$219.8M+2181.0%	$9.6M
Cash & Equivalents	$39.3M-30.3%	$56.4M+46.6%	$38.5M-42.3%	$66.6M-68.8%	$213.5M+2544.5%	$8.1M
Inventory	$1.5M-36.6%	$2.4M	N/A	$116K	N/A	N/A
Accounts Receivable	$112K+103.6%	$55K+61.8%	$34K	N/A	N/A	N/A
Goodwill	N/A	N/A	$7.4M-87.3%	$58.3M	N/A	N/A
Total Liabilities	$20.9M-9.7%	$23.1M-37.9%	$37.3M-47.5%	$71.0M+1214.5%	$5.4M-73.8%	$20.6M
Current Liabilities	$14.0M-10.0%	$15.5M-38.1%	$25.1M-52.5%	$52.8M+1077.5%	$4.5M-77.9%	$20.3M
Long-Term Debt	N/A	N/A	$3.5M	N/A	N/A	N/A
Total Equity	$189.1M-3.3%	$195.5M-9.8%	$216.7M-25.8%	$292.1M+26.6%	$230.7M+2728.7%	-$8.8M
Retained Earnings	-$373.7M-16.7%	-$320.2M-23.4%	-$259.5M-77.5%	-$146.2M-73.2%	-$84.4M-107.9%	-$40.6M

NNOX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$36.6M+18.3%	-$44.8M-3.2%	-$43.4M-14.0%	-$38.1M-76.1%	-$21.6M-291.2%	-$5.5M
Capital Expenditures	$2.8M-16.2%	$3.3M-53.9%	$7.2M-69.0%	$23.2M+66.2%	$13.9M+11049.6%	$125K
Free Cash Flow	-$39.4M+18.1%	-$48.1M+4.9%	-$50.6M+17.4%	-$61.2M-72.2%	-$35.5M-529.2%	-$5.6M
Investing Cash Flow	-$20.1M-156.6%	$35.4M+142.6%	$14.6M+112.6%	-$116.3M-734.6%	-$13.9M-11049.6%	-$125K
Financing Cash Flow	$39.5M+45.0%	$27.3M+3289.6%	$804K-89.1%	$7.4M-96.9%	$241.0M+1638.6%	$13.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

NNOX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	-94.0%-27.5pp	-66.5%+13.7pp	-80.2%+479.8pp	-560.0%	N/A	N/A
Operating Margin	-502.9%+129.0pp	-631.9%+740.3pp	-1372.2%+21427.0pp	-22799.3%	N/A	N/A
Net Margin	-474.3%+139.3pp	-613.6%+706.6pp	-1320.2%+21568.0pp	-22888.1%	N/A	N/A
Return on Equity	-28.3%+2.8pp	-31.1%+21.2pp	-52.3%-31.1pp	-21.1%-2.2pp	-19.0%	N/A
Return on Assets	-25.5%+2.3pp	-27.8%+16.8pp	-44.6%-27.6pp	-17.0%+1.5pp	-18.6%+171.5pp	-190.1%
Current Ratio	5.63-0.1	5.71+2.4	3.29+1.5	1.80-47.3	49.06+48.6	0.48
Debt-to-Equity	0.110.0	0.12+0.1	0.02-0.2	0.24+0.2	0.02+2.4	-2.35
FCF Margin	-348.9%+136.5pp	-485.4%+104.0pp	-589.4%+22084.3pp	-22673.7%	N/A	N/A

Metric	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	5.63-0.1	5.71+2.4	3.29+1.5	1.80-47.3	49.06+48.6	0.48
Debt-to-Equity	0.110.0	0.12+0.1	0.02-0.2	0.24+0.2	0.02+2.4	-2.35
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Quantum-Si Incorporated QSI

$161.8M

Viemed Healthcare Inc VMD

$371.7M

Outset Medical, Inc. OM

$73.4M

Perspective Therapeutics Inc CATX

$502.4M

Monogram Orthopaedics Inc MGRM

$243.8M

Frequently Asked Questions

What is Nano-X Imaging Ltd.'s annual revenue?

Nano-X Imaging Ltd. (NNOX) reported $11.3M in total revenue for fiscal year 2024. This represents a 13.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nano-X Imaging Ltd.'s revenue growing?

Nano-X Imaging Ltd. (NNOX) revenue grew by 13.9% year-over-year, from $9.9M to $11.3M in fiscal year 2024.

Is Nano-X Imaging Ltd. profitable?

No, Nano-X Imaging Ltd. (NNOX) reported a net income of -$53.5M in fiscal year 2024, with a net profit margin of -474.3%.

What is Nano-X Imaging Ltd.'s EBITDA?

Nano-X Imaging Ltd. (NNOX) had EBITDA of -$45.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Nano-X Imaging Ltd.'s gross margin?

Nano-X Imaging Ltd. (NNOX) had a gross margin of -94.0% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Nano-X Imaging Ltd.'s operating margin?

Nano-X Imaging Ltd. (NNOX) had an operating margin of -502.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Nano-X Imaging Ltd.'s net profit margin?

Nano-X Imaging Ltd. (NNOX) had a net profit margin of -474.3% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Nano-X Imaging Ltd.'s return on equity (ROE)?

Nano-X Imaging Ltd. (NNOX) has a return on equity of -28.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Nano-X Imaging Ltd.'s free cash flow?

Nano-X Imaging Ltd. (NNOX) generated -$39.4M in free cash flow during fiscal year 2024. This represents a 18.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Nano-X Imaging Ltd.'s operating cash flow?

Nano-X Imaging Ltd. (NNOX) generated -$36.6M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Nano-X Imaging Ltd.'s total assets?

Nano-X Imaging Ltd. (NNOX) had $210.0M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Nano-X Imaging Ltd.'s capital expenditures?

Nano-X Imaging Ltd. (NNOX) invested $2.8M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does Nano-X Imaging Ltd. spend on research and development?

Nano-X Imaging Ltd. (NNOX) invested $20.2M in research and development during fiscal year 2024.

How many shares does Nano-X Imaging Ltd. have outstanding?

Nano-X Imaging Ltd. (NNOX) had 64M shares outstanding as of fiscal year 2024.

What is Nano-X Imaging Ltd.'s current ratio?

Nano-X Imaging Ltd. (NNOX) had a current ratio of 5.63 as of fiscal year 2024, which is generally considered healthy.

What is Nano-X Imaging Ltd.'s debt-to-equity ratio?

Nano-X Imaging Ltd. (NNOX) had a debt-to-equity ratio of 0.11 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Nano-X Imaging Ltd.'s return on assets (ROA)?

Nano-X Imaging Ltd. (NNOX) had a return on assets of -25.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Nano-X Imaging Ltd.'s cash runway?

Based on fiscal year 2024 data, Nano-X Imaging Ltd. (NNOX) had $39.3M in cash against an annual operating cash burn of $36.6M. This gives an estimated cash runway of approximately 13 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Nano-X Imaging Ltd.'s Piotroski F-Score?

Nano-X Imaging Ltd. (NNOX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Nano-X Imaging Ltd.'s earnings high quality?

Nano-X Imaging Ltd. (NNOX) has an earnings quality ratio of 0.68x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Nano-X Imaging Ltd.?

Nano-X Imaging Ltd. (NNOX) scores 43 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.